PACLITERO 260MG

Paclitero 260 mg Injection is a medication used to combat cancer. It is effective in treating breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is characterized by the rapid and uncontrolled division and growth of cells. This Injection can be administered on its own or alongside other anticancer treatments. It is contraindicated in patients with severe liver issues, uncontrolled infections, and low levels of white blood cells or platelets.

Paclitero 260 mg is not advised for individuals under 18 years of age, including adolescents and children. If you have heart conditions, consult your doctor prior to using this medication. The administration of this drug may lead to severe allergic reactions. It is essential to use effective contraception during treatment and for at least six months following the final dose. This Injection may pose risks to individuals with a history of alcoholism, as it contains alcohol.